Power Law company profile

Telix Pharmaceuticals

Biotech & Life Sciences · Melbourne, Australia · Founded 2015 · IPO 2017 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$3.58B

Market cap · Apr/2026

Revenue

$804M

Latest reported FY

Global footprint

Where Telix Pharmaceuticals has talent and traffic

Web traffic by country

38K monthly visits
across markets

🇺🇸 United States27.1%

🇦🇺 Australia20.8%

🇯🇵 Japan6.3%

🇨🇦 Canada3.9%

🇬🇧 United Kingdom3.7%

Top 5 markets shown

Patent intelligence

$1M patent portfolio · 11 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$1M

0.03% of market cap · 109.5× smaller than top peer Deciphera Pharmaceuticals ($133M)

11 active patent families

Where Telix Pharmaceuticals innovates Cancer researchOncologyGrowth factorPharmacologyMolecular biology

Above peer median on Strategic, Economic

Quality vs same-sector peers

Telix Pharmaceuticals on the five Patsnap quality dimensions

Telix Pharmaceuticals in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Telix Pharmaceuticals concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Telix Pharmaceuticals and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Telix Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo